DEXCOM INC DXCM

Surgical & Medical Instruments & Apparatus · Nasdaq

기간	2026 Q3	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY
Revenues	$3.40B	$2.19B	$1.04B	$3.62B	$2.92B	$1.93B	$921.00M	$2.91B
Cost of Revenue	—	—	—	—	—	—	—	—
Gross Profit	$2.01B	$1.28B	$589.00M	$2.29B	$1.78B	$1.19B	$561.90M	$1.88B
R&D Expense	$450.90M	$293.40M	$145.20M	$505.80M	$412.90M	$277.50M	$141.50M	$484.20M
SG&A Expense	$969.50M	$638.10M	$310.10M	$1.19B	$958.40M	$652.00M	$319.30M	$1.01B
Operating Income (Loss)	$588.80M	$346.30M	$133.70M	$597.70M	$411.10M	$259.10M	$101.10M	$391.20M
Interest Expense	—	—	—	—	—	—	—	—
Net Income (Loss)	$569.00M	$285.20M	$105.40M	$541.50M	$424.50M	$289.90M	$146.40M	$341.20M
EPS (Diluted)	1.42	0.71	0.27	1.30	1.04	0.71	0.36	0.82

기간	2026 Q3	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY
Total Assets	$6.34B	$6.34B	$6.34B	$6.48B	$6.48B	$6.48B	$6.48B	$6.26B
Current Assets	$4.03B	$4.03B	$4.03B	$4.30B	$4.30B	$4.30B	$4.30B	$4.43B
Cash & Equivalents	$1.84B	$1.16B	$904.90M	$566.30M	$621.20M	$939.20M	$851.20M	$642.30M
Accounts Receivable	$1.22B	$1.22B	$1.22B	$1.01B	$1.01B	$1.01B	$1.01B	$973.90M
Inventory	$629.10M	$629.10M	$629.10M	$542.60M	$542.60M	$542.60M	$542.60M	$559.60M
PP&E (Net)	—	—	—	—	—	—	—	—
Goodwill	$24.20M	$24.20M	$24.20M	$22.80M	$22.80M	$22.80M	$22.80M	$25.20M
Total Liabilities	$3.59B	$3.59B	$3.59B	$4.38B	$4.38B	$4.38B	$4.38B	$4.20B
Current Liabilities	$2.14B	$2.14B	$2.14B	$2.93B	$2.93B	$2.93B	$2.93B	$1.56B
Long-Term Debt	—	—	—	—	—	—	—	—
Stockholders Equity	$2.10B	$2.10B	$2.10B	$2.13B	$2.07B	$2.07B	$2.07B	$2.04B

기간	2026 Q3	2026 Q2	2026 Q1	2025 FY	2025 Q3	2025 Q2	2025 Q1	2024 FY
Operating Cash Flow	$1.15B	$486.80M	$183.80M	$748.50M	$688.10M	$488.60M	$209.20M	$669.50M
Investing Cash Flow	$229.40M	$36.60M	$100.20M	$-507.20M	$96.20M	$-114.10M	$74.80M	$-521.50M
Financing Cash Flow	$-164.20M	$10.80M	$12.50M	$-318.60M	$-733.20M	$3.30M	$4.70M	$-552.50M
Stock Repurchases	$187.20M	$0	—	$688.70M	$750.00M	—	—	$557.70M

유사 기업

더 알아보기

데이터는 미국 SEC EDGAR 공공 데이터베이스에서 수집되었습니다. 이 사이트는 투자 조언을 제공하지 않습니다.